Chlorthalidone in chronic kidney disease (CLICK) randomized trial demonstrated a robust reduction in systolic blood pressure (BP) in stage 4 chronic kidney disease (CKD). Here we explore the mechanisms underlying the antihypertensive effect of chlorthalidone.